NCT03508687View on ClinicalTrials.gov

Study of Gemcabene in Adults With FPLD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Familial Partial LipodystrophyHypertriglyceridemiaFatty LiverNASH - Nonalcoholic Steatohepatitis
Interventions
DRUG

300mg Gemcabene

300mg Gemcabene

DRUG

600mg Gemcabene

600mg Gemcabene

Trial Locations (1)

48105

University of Michigan, Ann Arbor

All Listed Sponsors
lead

Elif Oral

OTHER

NCT03508687 - Study of Gemcabene in Adults With FPLD | Biotech Hunter | Biotech Hunter